Semaglutide has emerged as a novel treatment for type 2 diabetes. This manufactured glucagon-like peptide-1 (GLP-1) receptor agonist functions through stimulating the pancreas to produce more insulin and suppressing https://jessealye005718.qodsblog.com/35728353/understanding-semaglutide-a-comprehensive-guide